Key result
The C-reactive protein-triglyceride glucose index's prognostic value in acute myocardial infarction requires further validation controlling for CABG history, medication adherence, and AMI subtypes.
This letter highlights the necessity of addressing residual confounding, medication adherence, and AMI subtyping to accurately determine the prognostic value of the C-reactive protein-triglyceride glucose index.
reviewed open-access journal that welcomes laboratory and clinical findings on the molecular basis, cell biology and pharmacology of inflammation including original research, reviews, symposium reports, hypothesis formation and commentaries on: acute/chronic inflammation; mediators of inflammation; cellular processes; molecular mechanisms; pharmacology and novel anti-inflammatory drugs; clinical conditions involving inflammation.The manuscript management system is completely online and includes a very quick and fair peer-review system.
No takes yet. Share an insight, caveat, or question.
Yan et al. (2026) conducted a letter in Acute Myocardial Infarction. C-Reactive Protein-Triglyceride Glucose Index (CTI) was evaluated. The C-reactive protein-triglyceride glucose index's prognostic value in acute myocardial infarction requires further validation controlling for CABG history, medication adherence, and AMI subtypes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: